Role of Esrrg in the fibrate-mediated regulation of lipid metabolism genes in human ApoA-I transgenic mice

We have used a new ApoA-I transgenic mouse model to identify by global gene expression profiling, candidate genes that affect lipid and lipoprotein metabolism in response to fenofibrate treatment. Multilevel bioinformatical analysis and stringent selection criteria (2-fold change, 0% false discovery rate) identified 267 significantly changed genes involved in several molecular pathways. The fenofibrate-treated group did not have significantly altered levels of hepatic human APOA-I mRNA and plasma ApoA-I compared with the control group. However, the treatment increased cholesterol levels to 1.95-fold mainly due to the increase in high-density lipoprotein (HDL) cholesterol. The observed changes in HDL are associated with the upregulation of genes involved in phospholipid biosynthesis and lipid hydrolysis, as well as phospholipid transfer protein. Significant upregulation was observed in genes involved in fatty acid transport and β-oxidation, but not in those of fatty acid and cholesterol biosynthesis, Krebs cycle and gluconeogenesis. Fenofibrate changed significantly the expression of seven transcription factors. The estrogen receptor-related gamma gene was upregulated 2.36-fold and had a significant positive correlation with genes of lipid and lipoprotein metabolism and mitochondrial functions, indicating an important role of this orphan receptor in mediating the fenofibrate-induced activation of a specific subset of its target genes.

[1]  Jiandie D. Lin,et al.  Bioenergetic Analysis of Peroxisome Proliferator-activated Receptor γ Coactivators 1α and 1β (PGC-1α and PGC-1β) in Muscle Cells* , 2003, Journal of Biological Chemistry.

[2]  D. Knutti,et al.  The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha). , 2003, The Journal of biological chemistry.

[3]  P. Belfrage,et al.  Hormone-sensitive lipase and monoacylglycerol lipase are both required for complete degradation of adipocyte triacylglycerol. , 1986, Biochimica et biophysica acta.

[4]  Y. Kamei,et al.  PPARgamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Auwerx,et al.  Fibrates influence the expression of genes involved in lipoprotein metabolism in a tissue-selective manner in the rat. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[6]  T. Farag,et al.  Familial hypercholesterolemia. , 1988, Journal of the Royal Society of Medicine.

[7]  V. Laudet,et al.  The Nuclear Receptors Peroxisome Proliferator-activated Receptor α and Rev-erbα Mediate the Species-specific Regulation of Apolipoprotein A-I Expression by Fibrates* , 1998, The Journal of Biological Chemistry.

[8]  J. Auwerx,et al.  Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element. , 1994, The Journal of biological chemistry.

[9]  V. Mootha,et al.  Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1 , 1999, Cell.

[10]  G. Luc,et al.  Induction of the Phospholipid Transfer Protein Gene Accounts for the High Density Lipoprotein Enlargement in Mice Treated with Fenofibrate* , 2001, The Journal of Biological Chemistry.

[11]  Heri Ramampiaro,et al.  GeneTools – application for functional annotation and statistical hypothesis testing , 2006, BMC Bioinformatics.

[12]  D. Kelly,et al.  PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. , 2006, The Journal of clinical investigation.

[13]  Y. Horsmans,et al.  Pharmacodynamic activity of lipoprotein lipase and hepatic lipase, and pharmacokinetic parameters measured in normolipidaemic subjects receiving ciprofibrate (100 or 200 mg/day) or micronised fenofibrate (200 mg/day) therapy for 23 days. , 1996, Atherosclerosis.

[14]  L. Madsen,et al.  Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response. , 1999, Circulation.

[15]  K. Wassermann,et al.  Identification of hepatic transcriptional changes in insulin-resistant rats treated with peroxisome proliferator activated receptor-alpha agonists. , 2003, Journal of molecular endocrinology.

[16]  D. Moller,et al.  Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression. , 1998, Endocrinology.

[17]  Jiandie D. Lin,et al.  PGC-1beta in the regulation of hepatic glucose and energy metabolism. , 2003, The Journal of biological chemistry.

[18]  D. Vance,et al.  Targeted Deletion of Hepatic CTP:phosphocholine Cytidylyltransferase α in Mice Decreases Plasma High Density and Very Low Density Lipoproteins* , 2004, Journal of Biological Chemistry.

[19]  R. Evans,et al.  Identification of a new class of steroid hormone receptors , 1988, Nature.

[20]  J. Auwerx,et al.  Coordinate Regulation of the Expression of the Fatty Acid Transport Protein and Acyl-CoA Synthetase Genes by PPARα and PPARγ Activators* , 1997, The Journal of Biological Chemistry.

[21]  J. Świerczyński,et al.  Tissue-specific effect of clofibrate on rat lipogenic enzyme gene expression. , 1999, European journal of pharmacology.

[22]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[23]  D. Kardassis,et al.  Transcriptional regulatory mechanisms of the human apolipoprotein genes in vitro and in vivo , 2001, Current opinion in lipidology.

[24]  V. Giguère,et al.  Estrogen-Related Receptor α Directs Peroxisome Proliferator-Activated Receptor α Signaling in the Transcriptional Control of Energy Metabolism in Cardiac and Skeletal Muscle , 2004, Molecular and Cellular Biology.

[25]  P. Puigserver,et al.  Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. , 2003, Endocrine reviews.

[26]  L. Kunkel,et al.  Molecular profiles of inflammatory myopathies , 2002, Neurology.

[27]  J. Auwerx,et al.  Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. , 1995, The Journal of clinical investigation.

[28]  J. Auwerx,et al.  Apolipoprotein A-IV messenger ribonucleic acid abundance is regulated in a tissue-specific manner. , 1990, Endocrinology.

[29]  D. Kardassis,et al.  ApoA‐I Functions and Synthesis of HDL: Insights from Mouse Models of Human HDL Metabolism , 2008 .

[30]  J. Auwerx,et al.  Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice. , 1996, The Journal of clinical investigation.

[31]  H. Maegawa,et al.  Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha. , 2002, American journal of physiology. Endocrinology and metabolism.

[32]  V. Zannis,et al.  Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT. , 2007, The Biochemical journal.

[33]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[34]  X. Prieur,et al.  The Human Apolipoprotein AV Gene Is Regulated by Peroxisome Proliferator-activated Receptor-α and Contains a Novel Farnesoid X-activated Receptor Response Element* , 2003, Journal of Biological Chemistry.

[35]  J. Ntambi,et al.  Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. Carrino,et al.  Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[37]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Daniel P. Kelly,et al.  Peroxisome Proliferator-activated Receptor Coactivator-1α (PGC-1α) Coactivates the Cardiac-enriched Nuclear Receptors Estrogen-related Receptor-α and -γ , 2002, The Journal of Biological Chemistry.

[39]  Isaac S Kohane,et al.  Expression profiling reveals altered satellite cell numbers and glycolytic enzyme transcription in nemaline myopathy muscle , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[40]  V. Giguère,et al.  The orphan nuclear receptor estrogen-related receptor alpha is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene , 1997, Molecular and cellular biology.

[41]  J. Peters,et al.  Expression of Putative Fatty Acid Transporter Genes Are Regulated by Peroxisome Proliferator-activated Receptor α and γ Activators in a Tissue- and Inducer-specific Manner* , 1998, The Journal of Biological Chemistry.

[42]  J. Fruchart,et al.  Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism. , 2006, Drugs of today.

[43]  J. Saffitz,et al.  Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. , 2000, The Journal of clinical investigation.

[44]  Tong Liu,et al.  Point mutations in apolipoprotein A-I mimic the phenotype observed in patients with classical lecithin:cholesterol acyltransferase deficiency. , 2005, Biochemistry.

[45]  J. Auwerx,et al.  Acyl-CoA synthetase mRNA expression is controlled by fibric-acid derivatives, feeding and liver proliferation. , 1993, European journal of biochemistry.

[46]  R. Krauss,et al.  Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates. , 1995, The Journal of clinical investigation.

[48]  Neal F Cariello,et al.  Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[49]  G. Luc,et al.  Regulation of Human ApoA-I by Gemfibrozil and Fenofibrate Through Selective Peroxisome Proliferator–Activated Receptor &agr; Modulation , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[50]  Jonathan C. Cohen,et al.  An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing , 2001, Science.

[51]  V. Zannis,et al.  LDL receptor deficiency or apoE mutations prevent remnant clearance and induce hypertriglyceridemia in mice s⃞ , 2006, Journal of Lipid Research.

[52]  J. Auwerx,et al.  Perturbation of developmental gene expression in rat liver by fibric acid derivatives: lipoprotein lipase and alpha-fetoprotein as models. , 1992, Development.

[53]  E. Moran,et al.  DNA-binding properties of ARID family proteins , 2005, Nucleic acids research.

[54]  S. Wright,et al.  Regulation of lipid metabolism and gene expression by fenofibrate in hamsters. , 2001, Biochimica et biophysica acta.

[55]  K. Bulmer,et al.  Up-regulation of pyruvate dehydrogenase kinase isoform 4 (PDK4) protein expression in oxidative skeletal muscle does not require the obligatory participation of peroxisome-proliferator-activated receptor alpha (PPARalpha). , 2002, The Biochemical journal.

[56]  T. Wilt,et al.  Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. , 1999, The New England journal of medicine.

[57]  W. Roberts,et al.  Safety of fenofibrate--US and worldwide experience. , 1989, Cardiology.

[58]  A. Rigotti,et al.  A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[59]  Jiandie D. Lin,et al.  PGC-1β in the Regulation of Hepatic Glucose and Energy Metabolism* , 2003, Journal of Biological Chemistry.

[60]  L. Pennacchio,et al.  Apolipoprotein A5, a Crucial Determinant of Plasma Triglyceride Levels, Is Highly Responsive to Peroxisome Proliferator-activated Receptor α Activators* , 2003, The Journal of Biological Chemistry.

[61]  K. Hayes,et al.  Dietary modulation of apolipoprotein serum amyloid A (apoSAA) metabolism and prevention of amyloidosis in aging C57BL6J and SJLJ mice , 1997 .

[62]  J. Auwerx,et al.  Lecithin:cholesterol acyltransferase gene expression is regulated in a tissue-selective manner by fibrates. , 1992, Journal of lipid research.

[63]  Transcriptional profile of postmortem skeletal muscle. , 2004, Physiological genomics.

[64]  J. Brunzell.  Familial Lipoprotein Lipase Deficiency , 2011 .

[65]  Margaret S. Wu,et al.  Peroxisome Proliferator-Activated Receptors γ and α Mediate in Vivo Regulation of Uncoupling Protein (UCP-1, UCP-2, UCP-3) Gene Expression. , 1998, Endocrinology.

[66]  J. Huss,et al.  Peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-alpha and -gamma. Identification of novel leucine-rich interaction motif within PGC-1alpha. , 2002, The Journal of biological chemistry.

[67]  J. Breslow,et al.  High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3. , 1989, The Journal of biological chemistry.

[68]  D. Lan,et al.  Fenofibrate Induces a Novel Degradation Pathway for Scavenger Receptor B-I Independent of PDZK1* , 2005, Journal of Biological Chemistry.

[69]  Jiandie D. Lin,et al.  Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. , 2003, The Journal of biological chemistry.

[70]  Daniel P. Kelly,et al.  PGC-1α Coactivates the Cardiac-enriched Nuclear Receptors ERRα and γ via Novel Leucine-rich Interaction Interfaces , 2002 .

[71]  M. Krieger,et al.  Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL , 2006, Journal of Molecular Medicine.

[72]  J Auwerx,et al.  PPARalpha and PPARgamma activators direct a distinct tissue‐specific transcriptional response via a PPRE in the lipoprotein lipase gene. , 1996, The EMBO journal.

[73]  V. Giguère,et al.  Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle. , 2004, Molecular and cellular biology.

[74]  J. Peters,et al.  Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner. , 1998, The Journal of biological chemistry.

[75]  S. Georgopoulos,et al.  A Hormone Response Element in the Human Apolipoprotein CIII (ApoCIII) Enhancer Is Essential for Intestinal Expression of the ApoA-I and ApoCIII Genes and Contributes to the Hepatic Expression of the Two Linked Genes in Transgenic Mice* , 2000, The Journal of Biological Chemistry.

[76]  J. Komorowski,et al.  Liver gene expression in rats in response to the peroxisome proliferator-activated receptor-alpha agonist ciprofibrate. , 2003, Physiological genomics.

[77]  Y. Kamei,et al.  PPARγ coactivator 1β/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[78]  B. Miroux,et al.  Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production , 2000, Nature Genetics.

[79]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[80]  J. Auwerx,et al.  Down-regulation of hepatic lipase gene expression and activity by fenofibrate. , 1992, Biochimica et biophysica acta.

[81]  J. Mckenney,et al.  Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) , 1993, JAMA.

[82]  Rick B. Vega,et al.  A Role for Estrogen-related Receptor α in the Control of Mitochondrial Fatty Acid β-Oxidation during Brown Adipocyte Differentiation* , 1997, The Journal of Biological Chemistry.

[83]  V. Litvak,et al.  Maintenance of the diacylglycerol level in the Golgi apparatus by the Nir2 protein is critical for Golgi secretory function , 2005, Nature Cell Biology.

[84]  Anastasia Kralli,et al.  The Transcriptional Coactivator PGC-1 Regulates the Expression and Activity of the Orphan Nuclear Receptor Estrogen-Related Receptor α (ERRα)* , 2003, The Journal of Biological Chemistry.

[85]  L. Svensson,et al.  Peroxisome Proliferator-induced Long Chain Acyl-CoA Thioesterases Comprise a Highly Conserved Novel Multi-gene Family Involved in Lipid Metabolism* , 1999, The Journal of Biological Chemistry.